Citations 27
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Patterns of Lymphoproliferative Disorders in Ethiopia, Based on Single-Center Experience
Minayehu, Tirumebet Mezgebu, Begna, Kebede, Tola, Mesfin Asefa, Tabor, Biniyam Beyene , Mekonen, Yemesrach Fereja, Hilawi, Helen Gebremariyam, Asefa, Mesfin
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12137-12138
Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy
Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287
Monocytopenia As an Adverse Prognosticator in Vexas Syndrome
Kusne, Yael , Finke, Christy M. , Fernandez, Jenna A., Begna, Kebede, Bock, Allison M. , Reichard, Kaaren K. , Olteanu, Horatiu , Patnaik, Mrinal M. , Koster, Matthew J. , Warrington, Kenneth J. , Go, Ronald S. , Lasho, Terra L. , Herrick, Jennifer L.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11406-11407
Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome
Chhetri, Rakchha , Al‐Kali, Aref , Gangat, Naseema , Litzow, Mark R. , Begna, Kebede, Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Singhal, Deepak , Hogan, William J. , Kutyna, Monika , Alkhateeb, Hassan B. , Baranwal, Anmol , Shanmuganathan, Naranie , Kumar, Sharad , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6964-6965
A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of the ECOG-ACRIN EA9131 Trial
Jillella, Anand P., Altman, Jessica K. , Luger, Selina M. , Tallman, Martin S. , Foran, James M. , Law, Lisa Y. , Bryan, Locke J. , Zahr, Abdallah Abou, Begna, Kebede, Perl, Alexander E. , Vadakara, Joseph , Sánchez, Federico , Carlos, Ruth C. , Litzow, Mark R. , Lee, Sandra J. , Bergan, Raymond C. , Fisch, Michael , Wagner, Lynne I. , Kota, Vamsi
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1011-1013
Clinical and Molecular Characteristics of ETV6 Mutated Myeloid Malignancies
Chekkaf, Ismahene, He, Rong , Viswanatha, David S., Mangaonkar, Abhishek A. , Begna, Kebede, Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Gurney, Mark E. , Greipp, Patricia T. , Badar, Talha , Shah, Meera , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6912-6914